n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, August 4th, 2016

The QualityStocks
Daily Stock List

graphic
graphic

ZIVO Bioscience, Inc. (ZIVO)

Ceocast News and RedChip reported on ZIVO Bioscience, Inc. (ZIVO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

ZIVO Bioscience, Inc.’s commitment is to the study, development, and commercialization of naturally derived compounds and bioactive molecules created by algal and bacterial hosts. The Company has partnered with the Arizona Center for Algae Technology and Innovation (AzCATI) for its research and development (R&D) development programs. ZIVO Bioscience has its headquarters in Keego Harbor, Michigan. It previously went by the name Health Enhancement Products, Inc. It changed its name to ZIVO Bioscience, Inc. in November 2014. The Company’s wholly-owned subsidiary is WellMetris, LLC.

ZIVO Bioscience is re-inventing its Company as a licensor of internally developed intellectual property (IP), which includes its proprietary algae cultures, in addition to IP secured through strategic acquisitions. The Company’s dedication is to the ideal of promoting health through utilizing naturally occurring bioactive agents. These active ingredients are produced and processed to obtain the highest possible efficacy.

To maximize the value and earning power of licenses, ZIVO involves in continuing R&D to provide its licensees with the scientific and technical support needed to move into production and distribution. ZIVO Bioscience’s works to completely harness the beneficial effects of its natural bioactive agents and make them affordable and readily available in a useful and convenient form.

ZIVO Bioscience announced last year that it opened an assay development lab for its wholly-owned subsidiary, WellMetris LLC, in South Bend, Indiana at the Innovation Center near the Notre Dame University campus. The lab co-locates assay development and instrument engineering to streamline the product development process and focus on future development initiatives. In late 2015, ZIVO announced that WellMetris successfully concluded manufacturing runs of assays for its proprietary, patent-pending metabolic testing panel for human application. The manufacturing run completes the full wellness panel with the latest assay formulations.

ZIVO Bioscience has more recently continued to focus almost exclusively on dairy cow applications for its proprietary algal biomass, extracts and any high-value bioactive compounds thereof. This is while developing the business case and production scale-up to cultivate and productize this algal biomass.

Regarding its platform strategy, ZIVO’s core intellectual property (IP) consists of the algae culture itself, the patented process of producing that culture, and the bioactive compounds or molecules that can be extracted, and also the application of that culture or extract in supporting health maintenance and longevity. ZIVO’s intention is to approach the near-term markets first: animal applications, human food ingredients and human dietary supplements. This is while laying the foundation for the more complex and longer-term opportunities in the medicinal and pharmaceutical market verticals.

ZIVO Bioscience, Inc. (ZIVO), closed Thursday's trading session at $0.055, down 6.78%, on 74,235 volume with 10 trades. The average volume for the last 60 days is 35,885 and the stock's 52-week low/high is $0.021/$0.145.

Interleukin Genetics, Inc. (ILIU)

TopPennyStockMovers, Streetwise Reports, Zacks, MicroCap Gems, and FeedBlitz reported earlier on Interleukin Genetics, Inc. (ILIU), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

A life science company, Interleukin Genetics, Inc. develops and markets proprietary genetic tests for chronic diseases and health related conditions. In essence, the Company focuses on the genetics of chronic inflammation. Interleukin Genetics takes advantage of its research, intellectual property (IP), and genetic panel development expertise in metabolism and inflammation to facilitate the growing personalized healthcare market. Interleukin Genetics has its corporate headquarters in Waltham, Massachusetts.

The Company markets its tests via partnerships with health and wellness companies, healthcare professionals, and other distribution channels. It operates an on-site, state-of-the-art DNA testing laboratory certified under the Clinical Laboratories Improvements Amendments (CLIA).

Interleukin’s products encourage individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. The Company has two primary focus areas to its business. One is personalized health, centering on providing genetic information to physicians, dentists, and in some cases consumers. The second is a research and development (R&D) effort focused on developing genetic tests linked to a partner’s products for marketing and sales into medical and dental channels.   

Its flagship products include its proprietary PerioPredict® genetic risk panel for periodontal disease and tooth loss susceptibility sold through dentists, and the Inherent Health® Weight Management Genetic Test, which identifies the most effective diet and exercise program for an individual based on genetics. The Inherent Health brand of genetic tests also includes Nutritional Needs Genetic Test, Heart Health Genetic Test, and the Bone Health Genetic Test.

PerioPredict® is a unique, user-friendly genetic test. It identifies individuals with an increased risk for severe and progressive periodontitis.  PerioPredict® is made available to employees in covered health plans under the supervision of a licensed dentist or physician.  

Interleukin Genetics has been granted a patent by the European Patent Office (EPO) covering its Inherent Health® Weight Management Genetic Test. The granted patent is entitled “Genetic Markers for Weight Management and Methods of Use Thereof”. The European patent grants coverage of the Weight Management Genetic Test into 2029. Corresponding patents have been granted in major markets including Eurasia, Japan, Mexico, Russia and New Zealand.

Last month, Interleukin Genetics announced that it signed an agreement with Amway to provide Interleukin’s PerioPredict® Genetic Risk Test and Patient Engagement Platform to Amway’s employees as part of an enhanced employee benefits plan. With this agreement, Interleukin Genetics will make PerioPredict available to Amway’s approximately 5,000 employees in the United States. The expectation is that this program will start this September. Amway is a leading direct selling company.

Yesterday, Interleukin Genetics announced the appointment of two senior leaders to enhance its commercial team and capabilities. Mr. Stephan Toutain will join the Company as Chief Commercial Officer, and Ms. Mary Hiter will become Director of Marketing. These are both newly created roles at the Company. Mr. Toutain and Ms. Hiter will join Interleukin later this month.

Interleukin Genetics, Inc. (ILIU), closed Thursday's trading session at $0.1287, up 16.89%, on 32,800 volume with 10 trades. The average volume for the last 60 days is 22,807 and the stock's 52-week low/high is $0.01/$0.41.

Weyland Tech, Inc. (WEYL)

DreamTeamNetwork, Wall Street Mover, and OTCJournal reported on Weyland Tech, Inc. (WEYL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Hong Kong based Weyland Tech, Inc. is a provider of mobile business applications. The focus of the Company’s CreateApp platform is on the Asia markets. At present, Weyland Tech offers the CreateApp platform directly in Singapore, India (Jaipur), and the United States and Canada. Weyland Tech lists on the OTC Markets Group’s OTCQB.

The Company’s CreateApp platform is offered in 12 languages. It enables small-medium-sized businesses (SMB's) to create a mobile application (APP) without the requirement of technical knowledge and background. Therefore, SMB's can build sales, reach more customers, and also promote their products and services through a simple, easy-to-build mobile APP. They can do so in an affordable and cost-effective manner.

Currently, Weyland Tech offers a DIY (Do-it-Yourself) App builder by way of a 'white label' platform. It offers this via strategic partnerships in the EU (minus Russia, Turkey, Armenia, Azerbaijan); Malaysia; Hong Kong/South China; Indonesia; and North/Central/South America. It will offer this in Korea via IAM, Inc. (www.createapp.kr).

This past April, Weyland Tech announced that its U.S. partner, Aurum Digital signed its first Master Reseller Agreement with an entity focused on the martial arts industry. Aurum is a start-up company. Aurum formed to market and sell the CreateApp platform in the America's. Aurum signed a Master Reseller Agreement with a company that has an estimated 33,000 martial arts schools throughout North America, in its network.

Recently, Weyland Tech announced it entered into a Memorandum of Understanding (MOU) with 2C2P, the foremost Southeast Asian payments services company. 2C2P and Weyland Tech will work together on an m-commerce solution, which enables SMB’s to provide multi-payment options to consumers in the Southeast Asia region.

Moreover, Weyland Tech also recently announced that it signed a Master Service Agreement (MSA) with Orient Asia Pacific Limited (OAP). This is for the Indonesia market. OAP is a software and digital technology consulting enterprise.

OAP will market CreateApp products in Indonesia under the CreateApp Indonesia brand. Together with its regional and in-country partners in payment, distribution logistics and eCommerce fulfillment, OAP will deploy CreateApp mobile enabler applications in a unified end-to-end supply chain process to benefit merchants and customers in expanded markets.

Weyland Tech, Inc. (WEYL), closed Thursday's trading session at $2.10, even for the day, on 19,890 volume with 46 trades. The average volume for the last 60 days is 3,809 and the stock's 52-week low/high is $0.10/$3.03.

Formation Metals, Inc. (FMETF)

InvestorIntel reported recently on Formation Metals, Inc. (FMETF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed Formation Metals, Inc. is a mineral exploration and mine development company. Via its wholly-owned subsidiaries, it has interests in base and precious metals and uranium projects in the U.S., Canada, and Mexico. Incorporated in 1988, Formation Metals’ expertise includes its management and highly qualified team of consultants. These consultants comprise mining engineers, geologists, permitting, metallurgical and cobalt marketing specialists. Formation Metals is headquartered in Vancouver, British Columbia.

The Company's main asset is situated in Idaho. It is the 100 percent owned, fully NEPA permitted Idaho Cobalt Project (ICP). This Project consists of the mine and mill near Salmon, Idaho and the proposed Cobalt Production Facility (CPF) for refining ICP mine concentrate.

Formation Metals owns a 16-acre industrial zoned package of land near Kellogg, Idaho which is appropriate for the future placement of the CPF. In addition, the Company is investigating other locations for the refining facility optimally situated closer to the mine site and a railhead to lessen the operating expenditures of the ICP.

In April of 2015, Formation Metals announced the completion of a positive Preliminary Economic Assessment (PEA) on the ICP. The basis of the PEA is on an underground mine with a target production rate of 800 tons per day (tpd) with a weighted average annual production of 2,771,000 lbs. of cobalt, 4,533,000 lbs. of copper, and 3,600 oz. of gold. This is over a 12.5-year mine life with an estimated pre-production period of 21 months using a 0.20 percent cobalt cut-off.

The economic model uses a 35 percent corporate tax rate and an 8.5 percent discount rate. This results in an after tax NPV (Net Present Value) of $113.45M and an IRR (Internal Rate of Return) of 24.07 percent.

In June of this year, Formation Metals announced it signed an agreement with Micon International Limited for technical services to conduct a Bankable Feasibility Study on Formation's Idaho Cobalt Project (ICP). Micon will be subcontracting facets of the study regarding the processing, infrastructural engineering, risk assessment, project scheduling, and cost estimating to SNC-Lavalin, Inc.

Mr. Paul Farquharson, Formation Metals’ President & Chief Executive Officer, stated, “This development is a significant milestone in the advancement of the ICP towards production. As a result of our recently completed C$4.4M financing, we are now able to fast-track the engineering of the ICP. During this process, expected to culminate in Q1-2017, management will be actively pursuing additional financing opportunities with the ultimate goal of securing Capex financing to re-commence construction of our cobalt project.”

Formation Metals, Inc. (FMETF), closed Thursday's trading session at $0.4477, down 1.60%, on 31,900 volume with 10 trades. The average volume for the last 60 days is 37,992 and the stock's 52-week low/high is $0.059/$0.49.

Uniti Financial Corp. (UIFC)

We are reporting on Uniti Financial Corp. (UIFC) today, here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets Group’s OTCQB, Uniti Financial Corp. operates as a holding company for Uniti Bank. The Bank provides banking services to small and middle-market businesses and individuals. It does so mainly in Los Angeles and Orange Counties, California. Established in 2001, Uniti Financial has its corporate head office in Buena Park, California.

Uniti Bank commenced operations on December 17, 2001. It is the largest Korean-American bank based in Orange County, California. In July of 2005, Uniti Financial Corp. established as a bank holding company. At present, Uniti Bank is the sole subsidiary of the holding company.

Uniti Bank is a full-service business bank. The Bank is chartered under the authority granted by the California Department of Business Oversight. In addition, Uniti’s deposits are insured up to the maximum legal limit by the Federal Deposit Insurance Corporation (FDIC).

Uniti Bank operates three branches in Buena Park, Garden Grove, and Los Angeles, California. Pertaining to its Personal Banking offerings, Uniti Banks offers Personal Checking, Personal Savings, and Personal Certificates of Deposits (CD’s). It also offers Personal Loans.

Regarding its Business Banking offerings, it offers Business Checking, Business Savings, and Business CD’s. It also offers Business Loans and SBA Loans. Concerning Cash Management, it offers AR Solutions, AP Solutions, as well as Information Solutions. AR Solutions include ACH Collection, ACH Notification, LockBox, Merchant Processing, Remote Deposit, SmartPay, and Express Invoice.

AP Solutions include ACH Payable, ACH Notification, Business Payroll, Positive Pay, as well as Online Wire. With Cash Management ACH Payable Solutions, Uniti Bank ACH Payable services use the ACH network to Direct Deposit employee paychecks or make routine monthly payments to vendors. Therefore, organizations (with the ability to process personal expense reimbursements and accounts payable) can use ACH to manage cash flow and improve cash flow forecasting. Information Solutions include Business Online Banking and eStatement.

Uniti Bank offers savings accounts consisting of money market and regular savings accounts. It provides business loans, including commercial term, commercial real estate, and professional loans, and also commercial business lines of credit; and personal loans consisting of consumer loans.

Uniti Financial Corp. (UIFC), closed Thursday's trading session at $2.30, even for the day. The average volume for the last 60 days is 2,673 and the stock's 52-week low/high is $2.07/$2.65.

graphic

The QualityStocks
Company Corner

graphic
graphic

Alternet Systems, Inc. (ALYI)

The QualityStocks Daily Newsletter would like to spotlight Alternet Systems, Inc. (ALYI). Today, Alternet Systems, Inc. closed trading at $0.004, up 60.00%, on 41,500 volume with 6 trades. The stock’s average daily volume over the past 60 days is 96,306, and its 52-week low/high is $0.0025/$0.029.

Alternet Systems, Inc. (ALYI) invests in and partners with companies that are creating the future of money in the high growth, emerging technology fields of digital commerce, multichannel payments, and predictive analytics.

Vision: Be the leading digital commerce, multichannel payments, predictive analytics solutions provider into global markets

Mission: To provide innovative solutions that facilitates and expedites commerce, enriching our partners and their customers' experience, and improving efficiency. Recognizing that the world is becoming increasingly dependent on technological conveniences, Alternet Systems aims to provide its customers with the tools to prepare themselves for a new era of digital commerce and payments, financial services and consumer information, and, most importantly, a new era of how to live.

Since 2010, Alternet has maintained a progressive focus on the high-growth, mobile value-added service industries of mobile financial services and mobile security. In 2014, the company expanded its scope of expertise to include in its investment verticals the exciting digital commerce space, transforming the legacy electronic payments infrastructure and developing advanced predictive data analytics applications for the mass consumer, telecommunications and financial industry.

With strategic investments in these three key, high-growth markets, Alternet is accelerating the future of money and its role in the global demand for these services. The company is guided by a team of executives specializing in entrepreneurial endeavors, innovation, corporate strategy, financial and executive management of multi-national organizations, and a vast network of industry resources.

As Alternet embarks on this new path, the company will be led by a management team and board of directors with over a century's worth of combined experience in the fields of investing, technology, and financing, and the consensus knowledge of where to invest and when in start-up and early-stage companies. Disclaimer

Alternet Systems, Inc. Company Blog

Alternet Systems, Inc. News:

Alternet Systems Data Analytics Solution Gains Momentum with New Clients and Partners

Alternet Systems Announces Caprock Research Report with Near Term Price Target of $0.05 and 'Accumulate' Recommendation

Alternet Systems Launches Data Analytics Division To Build On Existing Revenue Base

Laguna Blends Inc. (LAGBF)

The QualityStocks Daily Newsletter would like to spotlight Laguna Blends Inc. (LAGBF). Today, Laguna Blends Inc. closed trading at $0.23, up 13.30%, on 12,500 volume with 4 trades. The stock’s average daily volume over the past 60 days is 18,604, and its 52-week low/high is $0.069/$0.261.

Laguna Blends Inc. (LAGBF) is a network marketing company focused on the generation of sales through independent affiliates. Leveraging innovative tools and technologies, the company's affiliates are able to build international businesses from their own homes while effectively capitalizing on the performance of some of the world's most rapidly expanding, in-demand markets. To date, Laguna's primary focus has been on the hyper growing hemp food and beverage marketplace. As part of these efforts, the company introduced Caffe, a hemp-infused instant coffee product, and is preparing to launch Pro369, a water soluble hemp protein powder.

As a network marketing company, Laguna is strategically positioned to grow very quickly following its entry into the rapidly expanding hemp market space. In early March 2016, the company gave prospective shareholders a preview of this potential when it launched sales of its protein coffee beverage through 135 independent affiliates throughout the United States and Canada. In less than a week, Laguna's affiliate base grew by more than 100 percent to include 278 independent marketers, demonstrating the high levels of demand for functional beverage products across North America, as well as the considerable interest in the viable business opportunity Laguna presents to its affiliates.

Through the commercialization of Caffe and Pro369, Laguna is establishing a foothold in two high-demand global markets. According to reports from the Coffee Association of Canada (CAC), coffee is consumed by a larger proportion of adults than any other beverage, excluding water. In recent years, the emergence of energy drinks has slowed the coffee industry's performance, but the single cup serving market, of which Caffe is a part, has maintained steady growth, rising above 32 percent market share as of January 2014, according to Mintel Research. With a product in this space - as well as the global hemp industry, which was valued at nearly $500 million in 2012 by the Hemp Industries Association - Laguna's initial offerings position it strongly for sustainable growth.

With growth through its marketing network already underway, Laguna has turned its attention toward further expansion of its product line. In March 2016, the company signed a letter of intent with Robert Lamberton Consulting regarding the development of a "Limitless functional beverage brain health and memory coffee" product. Under the terms of this LOI, all hard costs associated with the development of the product will be billed to Robert Lamberton Consulting. The two parties are expected to enter into a formal research and development agreement outlining the details of this arrangement in the second quarter of 2016.

Laguna is the first network marketing Company to use exciting virtual 3D technology to enable affiliates to train, recruit and drive sales by utilizing a simple interactive platform. Laguna believes this technology is a game changer in the Direct Selling / Network Marketing Industry. Disclaimer

Laguna Blends Inc. Company Blog

Laguna Blends Inc. News:

Laguna Recaps Key Milestones, Drivers to Corporate Growth Strategy

Laguna Announces that the Clinical Trial Data of CBD Cannaceuticals Facial Serum Resulted in a 100% Overall Improvement of the Skin Appearance Within Two Weeks

Laguna Signs Letter of Intent to Acquire Distribution Rights of Swiss Made Cannaceuticals CBD Skin Care Line and License of Brand Name in an Exclusive Licence Agreement that Includes Clinical Trials and Existing Inventory

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $2.00, up 4.71%, on 9,356 volume with 23 trades. The stock’s average daily volume over the past 60 days is 4,646, and its 52-week low/high is $1.50/$6.95.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.

The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.

In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation Announces Successful Cell Transplantation for the First Patient in Phase 1 Clinical Trial of ISC-hpNSC

International Stem Cell Corporation Announces Publication of Preclinical Results Demonstrating Treatment of Parkinson's Disease in Cell Transplantation

Cryoport to Provide Cold Chain Logistics Support for International Stem Cell Corporation's Phase I Clinical Trial for the Treatment of Parkinson's Disease

WRIT Media Group, Inc. (WRIT)

The QualityStocks Daily Newsletter would like to spotlight WRIT Media Group, Inc. (WRIT). Today, WRIT Media Group, Inc. closed trading at $0.20, up 2.56%, on 33,206 volume with 18 trades. The stock’s average daily volume over the past 60 days is 107,612, and its 52-week low/high is $0.13/$1.50.

WRIT Media Group, Inc. (WRIT) is a diversified media and software company focused on expanding in the digital media industry. The company specializes in production and distribution; video game distribution via mobile platforms; and digital currency software development, including trading platforms and Blockchain solutions. WRIT's current portfolio includes Front Row Networks, Retro Infinity, Amiga Games and Pandora Venture Capital.

Front Row Networks is a content creation company that produces, acquires and distributes live event programming for initial worldwide digital broadcast into digitally enabled movie theaters and online streaming.

Software company Amiga Games is resurrecting the Amiga brand by publishing popular retro video games of the past for use on today's smartphones, modern game consoles, micro-consoles, PCs, and tablets.

Retro Infinity, Inc. serves as a video game distribution portal which publishes video games from Amiga, Atari, and other retro brands. The company leverages these platform and classic game brands, coupled with proprietary technologies, to create new revenue from dormant game libraries.

Pandora Venture Capital is a software developer with a focus on digital currency technologies, including a cryptocurrency trading platform, a new generation of cryptocurrency, and Blockchain technology solutions. Blockchain technology is emerging as a useful technology solution in payment processing, loyalty rewards, healthcare record management, insurance, and legal contracts management.

Together with its subsidiaries, WRIT Media Group is focused on benefitting from the widespread market growth and increased demand for alternative theatrical, mobile and interactive content, as well as digital currency. Disclaimer

WRIT Media Group, Inc. Company Blog

WRIT Media Group, Inc. News:

WRIT Media Group Announces New Funding Round

WRIT Media Group Announces Development of Blockchain-Based Payment Systems

WRIT Media Group Details Pandora Venture Capital Corp. Acquisition

Star Mountain Resources, Inc. (SMRS)

The QualityStocks Daily Newsletter would like to spotlight Star Mountain Resources, Inc. (SMRS). Today, Star Mountain Resources, Inc. closed trading at $0.31, even for the day, on 14,218 volume with 1 trade. The stock’s average daily volume over the past 60 days is 3,671, and its 52-week low/high is $0.30/$1.18.

Star Mountain Resources, Inc. (SMRS), a minerals exploration company, is focused on acquiring and consolidating mining claims, mineral leases, producing mines, and historic mines with production and future growth potential identified through exploration efforts. The company's operations are currently focused on the initiation, production and expansion of acquired mineral resources in the Star Mountain Mining District, Beaver County, Utah and turning them into producing assets.

Comprised of 2,320 acres, the company's Star Mountain/Chopar Mine project consists of 116 lode-mining claims and four metalliferous mineral lease sections located in the Star Mountain range, Star Mining District, in Beaver County, Utah, approximately five miles west of Milford, Utah. Exploration activities to date include geological analysis, and a limited reverse circulation & core drilling program.

The Star Mountain Mining District, which is dotted with historic mines dating back to the late 1800s, has a long and storied history within the mining industry. The company believes that the application of modern exploration tools will reveal additional resources that were previously unattainable. Leveraging the region's mild climate and accessibility to nearby rail lines and roads, management will look to translate this potential into sustainable returns in the years to come.

Star Mountain Resources has adopted a discovery-based business model to grow its industry presence in the future. The company plans to thoroughly explore and initially develop its leasehold before seeking senior industry partners to assist in the capital-intensive development and operation phases. Building on this strategy, Star Mountain Resources will also continue to seek quality projects that can be evaluated on their own technical and financial merit. Disclaimer

Star Mountain Resources, Inc. Company Blog

Star Mountain Resources, Inc. News:

Star Mountain Resources Subsidiary Secures $500,000 Loan From a New York Public Benefit Trust

Star Mountain Resources Receives Industry Guide 7 Mineral Reserves Report on Balmat Mine

Star Mountain Resources, Inc. Closes Acquisition of Balmat Zinc Mine in New York State

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

QualityStocks
(ALYI)

2.

Profitable Trader Authority
(CLOW)

3.

Marketbeat.com
(IL)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251